BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9089561)

  • 1. The effect of hormone replacement therapy on vitamin E status in postmenopausal women.
    Wen Y; Doyle MC; Harrison RF; Feely J
    Maturitas; 1997 Mar; 26(2):121-4. PubMed ID: 9089561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Tocopherol and beta-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate.
    Clemente C; Caruso MG; Berloco P; Buonsante A; Giannandrea B; Di Leo A
    Horm Metab Res; 1996 Oct; 28(10):558-61. PubMed ID: 8934216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.
    Wen Y; Doyle MC; Norris LA; Sinnott MM; Cooke T; Harrison RF; Feely J
    Br J Clin Pharmacol; 1999 Mar; 47(3):315-21. PubMed ID: 10218915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy.
    Wander RC; Du SH; Ketchum SO; Rowe KE
    Am J Clin Nutr; 1996 Feb; 63(2):184-93. PubMed ID: 8561059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women.
    Binder EF; Birge SJ; Kohrt WM
    J Am Geriatr Soc; 1996 Mar; 44(3):231-6. PubMed ID: 8600189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
    Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
    JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
    Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
    Carr BR; Khan N; Adams-Huet B; Kakarla N; Havelock JC; Gell J
    Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
    JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial.
    Ossewaarde ME; Dallinga-Thie GM; Bots ML; van der Schouw YT; Rabelink TJ; Grobbee DE; Westerveld HT
    Eur J Clin Invest; 2003 May; 33(5):376-82. PubMed ID: 12713450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.